Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens

Viral infections in cats can cause serious diseases and even death. Vaccines protect animals from diseases by inducing antibody production and cellular immune response. Primary and booster vaccinations are performed in accordance with the recommendations for the use of vaccines prescribed by the man...

Full description

Saved in:
Bibliographic Details
Main Authors: T. S. Galkina, A. A. Komarova, A. M. Kiselev
Format: Article
Language:English
Published: Da Vinci Media 2024-06-01
Series:Ветеринария сегодня
Subjects:
Online Access:https://veterinary.arriah.ru/jour/article/view/815
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086739666075648
author T. S. Galkina
A. A. Komarova
A. M. Kiselev
author_facet T. S. Galkina
A. A. Komarova
A. M. Kiselev
author_sort T. S. Galkina
collection DOAJ
description Viral infections in cats can cause serious diseases and even death. Vaccines protect animals from diseases by inducing antibody production and cellular immune response. Primary and booster vaccinations are performed in accordance with the recommendations for the use of vaccines prescribed by the manufactures depending on the minimum duration of immunity. In case of feline panleukopenia, antibody titers correlate with the protection against infection, as for feline calicivirus infection and feline rhinotracheitis, there is no such correlation or it is less clear. Vaccination of cats against these diseases has been performed in the Russian Federation for many years, nevertheless, the feline panleukopenia virus (FPV), feline calicivirus (FCV) and feline herpesvirus (FHV) are still the main common cause of morbidity and mortality among cats. Virus-carrying cats play an important role in the transmission of respiratory viruses such as FHV and FCV in the feline population, and the long-term persistence of FPV in the body, stability in the environmental conditions and resistance to disinfecting agents can be a potential cause of the infection in susceptible kittens. Due to variety of antigenically different FCV strains, the use of the vaccines containing two or more viral strains may induce a broader heterologous protection. The purpose of this work was to evaluate the effectiveness of the vaccine against feline panleukopenia, feline calicivirus infection and feline viral rhinotracheitis developed at the Federal Center for Animal Health (Vladimir) subordinate to the Rosselkhoznadzor, containing 2 heterologous FCV strains (Pers strain genotype I and Fauna strain genotype II), FPV Sheba strain and FHV Lavr strain. The product was developed and tested for its quality in accordance with the requirements of the Russian Federation law. Clinical studies were conducted using 8–12 week-old kittens from different litters born from seronegative, non-vaccinated cats and kept in the household, in a veterinary hospital and animal shelters. The product has successfully passed comprehensive quality control and is registered in the territory of the Russian Federation.
format Article
id doaj-art-79b950142af640a38c389f174cb0a31c
institution Kabale University
issn 2304-196X
2658-6959
language English
publishDate 2024-06-01
publisher Da Vinci Media
record_format Article
series Ветеринария сегодня
spelling doaj-art-79b950142af640a38c389f174cb0a31c2025-02-06T09:52:10ZengDa Vinci MediaВетеринария сегодня2304-196X2658-69592024-06-0113216417010.29326/2304-196X-2024-13-2-164-170667Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittensT. S. Galkina0A. A. Komarova1A. M. Kiselev2Federal Centre for Animal HealthFederal Centre for Animal HealthFederal Centre for Animal HealthViral infections in cats can cause serious diseases and even death. Vaccines protect animals from diseases by inducing antibody production and cellular immune response. Primary and booster vaccinations are performed in accordance with the recommendations for the use of vaccines prescribed by the manufactures depending on the minimum duration of immunity. In case of feline panleukopenia, antibody titers correlate with the protection against infection, as for feline calicivirus infection and feline rhinotracheitis, there is no such correlation or it is less clear. Vaccination of cats against these diseases has been performed in the Russian Federation for many years, nevertheless, the feline panleukopenia virus (FPV), feline calicivirus (FCV) and feline herpesvirus (FHV) are still the main common cause of morbidity and mortality among cats. Virus-carrying cats play an important role in the transmission of respiratory viruses such as FHV and FCV in the feline population, and the long-term persistence of FPV in the body, stability in the environmental conditions and resistance to disinfecting agents can be a potential cause of the infection in susceptible kittens. Due to variety of antigenically different FCV strains, the use of the vaccines containing two or more viral strains may induce a broader heterologous protection. The purpose of this work was to evaluate the effectiveness of the vaccine against feline panleukopenia, feline calicivirus infection and feline viral rhinotracheitis developed at the Federal Center for Animal Health (Vladimir) subordinate to the Rosselkhoznadzor, containing 2 heterologous FCV strains (Pers strain genotype I and Fauna strain genotype II), FPV Sheba strain and FHV Lavr strain. The product was developed and tested for its quality in accordance with the requirements of the Russian Federation law. Clinical studies were conducted using 8–12 week-old kittens from different litters born from seronegative, non-vaccinated cats and kept in the household, in a veterinary hospital and animal shelters. The product has successfully passed comprehensive quality control and is registered in the territory of the Russian Federation.https://veterinary.arriah.ru/jour/article/view/815feline panleukopeniafeline calicivirus infectionfeline viral rhinotracheitispreventionvaccine safety and efficacy
spellingShingle T. S. Galkina
A. A. Komarova
A. M. Kiselev
Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens
Ветеринария сегодня
feline panleukopenia
feline calicivirus infection
feline viral rhinotracheitis
prevention
vaccine safety and efficacy
title Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens
title_full Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens
title_fullStr Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens
title_full_unstemmed Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens
title_short Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens
title_sort clinical efficacy studies of the vaccine against feline panleukopenia calicivirus infection and viral rhinotracheitis carnifel pch in kittens
topic feline panleukopenia
feline calicivirus infection
feline viral rhinotracheitis
prevention
vaccine safety and efficacy
url https://veterinary.arriah.ru/jour/article/view/815
work_keys_str_mv AT tsgalkina clinicalefficacystudiesofthevaccineagainstfelinepanleukopeniacalicivirusinfectionandviralrhinotracheitiscarnifelpchinkittens
AT aakomarova clinicalefficacystudiesofthevaccineagainstfelinepanleukopeniacalicivirusinfectionandviralrhinotracheitiscarnifelpchinkittens
AT amkiselev clinicalefficacystudiesofthevaccineagainstfelinepanleukopeniacalicivirusinfectionandviralrhinotracheitiscarnifelpchinkittens